Login to Your Account

NewCo News

Rare Disease Firm Audentes Closes $30M Series A Financing

By Catherine Shaffer
Staff Writer

Friday, July 19, 2013
Audentes Inc., of San Francisco, closed a Series A financing round worth $30 million. OrbiMed Advisors led the round with participation by 5AM Ventures and Versant Ventures.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription